1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Immunoglobulin A Nephropathy (IgAN): new trials by email Literature Review of Immunoglobulin A Nephropathy (IgAN) trials Research Report on Immunoglobulin A Nephropathy (IgAN)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) Felzartamab, Placebo - Immunoglobulin A Nephropathy (IgAN) | Phase 3 | Recruiting | Biogen | 454 | 2025-05-08 | 2026-10-14 |
Autoimmune Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glomerulonephritis (1) · Immune System Diseases (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Nephritis (1) · Urogenital Diseases (1) · Urologic Diseases (1)
felzartamab (1)
Biogen (1)
Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1) · China (1) · Colombia (1) · Croatia (1) · Czechia (1) · France (1) · Germany (1) · Greece (1) · India (1) · Italy (1)